Bilateral subconjunctival hemorrhage secondary to abciximab use: case report


Creative Commons License

Kul S., Sayın M. R.

Sao Paulo Medical Journal, cilt.137, sa.2, ss.209-211, 2019 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 137 Sayı: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1590/1516-3180.2017.0182150717
  • Dergi Adı: Sao Paulo Medical Journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.209-211
  • Anahtar Kelimeler: Conjunctivitis, acute hemorrhagic, Abciximab [supplementary concept], Coronary disease
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab. CASE REPORT: A 40-year-old male patient underwent coronary angiography after acute anterior myocardial infarction and a coronary stent was placed. Abciximab was added to the therapy because of stent thrombosis. Bilateral subconjunctival hemorrhage was observed after the administration of the abciximab treatment. We treated our patient by stopping abciximab and administering artificial tears. CONCLUSİON: For the first time in the literature, we presented the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab, which was managed conservatively.